Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 4Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Postoperative Cognitive Complications 1Peptic Ulcer 1Pancreatic Neoplasms 1Pain 1Neoplasm Metastasis 1Hypesthesia 1Gastritis 1Esophageal Neoplasms 1Emergence Delirium 1Dyspepsia 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Fluorouracil 98Oxaliplatin 94Leucovorin 86Irinotecan 70Gemcitabine 66Bevacizumab 62Capecitabine 60Cetuximab 42pembrolizumab 37Cisplatin 30Nivolumab 25Drug Therapy 25130-nm albumin-bound paclitaxel 22Specimen Handling 20Folfox protocol 20Panitumumab 19Paclitaxel 19Magnetic Resonance Spectroscopy 18Albumin-Bound Paclitaxel 17Biopsy 16IFL protocol 15Floxuridine 15Docetaxel 15Cyclophosphamide 15Sorafenib 14regorafenib 12Erlotinib Hydrochloride 12aflibercept 11Radiofrequency Ablation 11fludarabine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Minocycline × Gastrointestinal × Clear all
NCT01693523 2020-03-09

Minocycline Study in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 10 charts
Gastrointestinal

cyclopia sequence, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡